KR0145525B1 - 지방족 2-히드록시산을 갖는 1-벤질-3-히드록시메틸-인다졸의 에테르 - Google Patents

지방족 2-히드록시산을 갖는 1-벤질-3-히드록시메틸-인다졸의 에테르

Info

Publication number
KR0145525B1
KR0145525B1 KR1019900001453A KR900001453A KR0145525B1 KR 0145525 B1 KR0145525 B1 KR 0145525B1 KR 1019900001453 A KR1019900001453 A KR 1019900001453A KR 900001453 A KR900001453 A KR 900001453A KR 0145525 B1 KR0145525 B1 KR 0145525B1
Authority
KR
South Korea
Prior art keywords
formula
compound
alkyl
benzyl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1019900001453A
Other languages
English (en)
Korean (ko)
Other versions
KR900012913A (ko
Inventor
실베스트리니 브루노
바이오찌 레안드로
Original Assignee
마리오 지오반니 갈라찌, 아르칸젤로 쉬아불리
아지엔데 키미케 리우니테 안젤리니 프란세스코 에이.시.알.에이.에프.에스.페.아.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 마리오 지오반니 갈라찌, 아르칸젤로 쉬아불리, 아지엔데 키미케 리우니테 안젤리니 프란세스코 에이.시.알.에이.에프.에스.페.아. filed Critical 마리오 지오반니 갈라찌, 아르칸젤로 쉬아불리
Publication of KR900012913A publication Critical patent/KR900012913A/ko
Application granted granted Critical
Publication of KR0145525B1 publication Critical patent/KR0145525B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
KR1019900001453A 1989-02-07 1990-02-07 지방족 2-히드록시산을 갖는 1-벤질-3-히드록시메틸-인다졸의 에테르 Expired - Fee Related KR0145525B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT47620A/89 1989-02-07
IT8947620A IT1230441B (it) 1989-02-07 1989-02-07 Eteri della serie dell'indazolo

Publications (2)

Publication Number Publication Date
KR900012913A KR900012913A (ko) 1990-09-03
KR0145525B1 true KR0145525B1 (ko) 1998-08-17

Family

ID=11261479

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900001453A Expired - Fee Related KR0145525B1 (ko) 1989-02-07 1990-02-07 지방족 2-히드록시산을 갖는 1-벤질-3-히드록시메틸-인다졸의 에테르

Country Status (36)

Country Link
US (2) US4999367A (enExample)
EP (1) EP0382276B1 (enExample)
JP (1) JP2870925B2 (enExample)
KR (1) KR0145525B1 (enExample)
CN (2) CN1046505C (enExample)
AR (1) AR247386A1 (enExample)
AT (1) ATE127115T1 (enExample)
AU (1) AU624895B2 (enExample)
BG (1) BG50273A3 (enExample)
CA (1) CA2009503C (enExample)
CZ (1) CZ280121B6 (enExample)
DD (2) DD295363A5 (enExample)
DE (2) DE69021902T2 (enExample)
DK (1) DK0382276T3 (enExample)
EG (1) EG19170A (enExample)
ES (1) ES2020171T3 (enExample)
FI (1) FI102678B1 (enExample)
GE (1) GEP19971030B (enExample)
GR (2) GR910300073T1 (enExample)
HU (1) HU204793B (enExample)
IL (1) IL93132A (enExample)
IN (1) IN170957B (enExample)
IT (1) IT1230441B (enExample)
LT (1) LT3604B (enExample)
LV (1) LV10612B (enExample)
NZ (1) NZ232258A (enExample)
PE (1) PE25091A1 (enExample)
PH (1) PH26552A (enExample)
PL (2) PL163720B1 (enExample)
PT (1) PT93067B (enExample)
RO (1) RO106252B1 (enExample)
RU (3) RU2066318C1 (enExample)
SK (1) SK278441B6 (enExample)
UA (1) UA26852C2 (enExample)
YU (1) YU47943B (enExample)
ZA (1) ZA90644B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1253703B (it) * 1991-04-22 1995-08-23 Angelini Francesco Ist Ricerca Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
IT1293795B1 (it) * 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1
US5943270A (en) * 1997-11-26 1999-08-24 Intel Corporation Two-transistor DRAM cell for logic process technology
US7514463B2 (en) * 2004-08-20 2009-04-07 University Of Kansas Lonidamine analogues and their use in male contraception and cancer treatment
ITMI20062254A1 (it) * 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
EA018185B1 (ru) 2008-03-07 2013-06-28 Ацьенде Кимике Рьюните Анджелини Франческо A.К.P.A.Ф. С.П.А. Новые производные 1-бензил-3-гидроксиметилиндазола и их применение при лечении заболеваний, обусловленных экспрессией mcp-1 или cx3cr1
DK2254869T3 (en) 2008-03-07 2017-09-04 Acraf 1-BENZYL-3-HYDROXYMETHYL INDAZOLE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF CX3CR1 AND P40
MX2010009625A (es) 2008-03-07 2010-09-28 Acraf Derivados de 1-bencil-3-hidroximetilindazol y uso de los mismos en el tratamiento de enfermedades basadas en la expresion de mcp-1, cx3cr1 y p40.
BR112012002130A2 (pt) * 2009-08-03 2015-09-15 Aziende Chimique Riunite Angelini Francesco A C R A F S P A processo para a preparação de composto,e, composto intermediário
UA108742C2 (uk) * 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
CA3095012C (en) 2012-05-01 2023-02-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
JP2015521183A (ja) 2012-05-18 2015-07-27 サノフイ ピリジン誘導体および病理学的血栓形成に関連する状態の治療へのその使用
DK2882715T3 (en) 2012-05-18 2017-02-13 Sanofi Sa PYRAZOL DERIVATIVES AND USE THEREOF AS LPAR5 ANTAGONISTS
CN108047136B (zh) * 2017-12-20 2021-07-09 长春普华制药股份有限公司 一种苄达酸的精制方法
AU2019441740B2 (en) 2019-04-18 2025-12-18 Tracery Ophthalmics Inc. Detection, prediction, and classification for ocular disease
EP3990433B1 (en) * 2019-06-25 2026-05-20 Translatum Medicus Inc. PROCESSES FOR THE MANUFACTURE OF 2-((1-BENZYL-1H-INDAZOL-3-YL)METHOXY)-2-METHYLPROPANOIC ACID AND ITS DERIVATIVES
CN113929627A (zh) * 2021-10-19 2022-01-14 吕梁学院 一种宾达利的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL28032A (en) * 1966-08-29 1971-08-25 Acraf Indazol-3-yl-oxyalkanoic acids and process for the preparation thereof
US3470298A (en) * 1969-01-29 1969-09-30 Acraf Topical anti-inflammatory composition containing (indazole-3-yl)-oxyalkanoic acids
IT1131779B (it) 1980-07-29 1986-06-25 Acraf Sale dell'acido (1-benzil-1h-indazol-3-il)-ossiacetico con la lisina e procedimento per la sua preparazione
IT1189052B (it) 1981-11-27 1988-01-28 Acraf Trattamento della cataratta
IT1194564B (it) 1983-04-18 1988-09-22 Acraf Impiego del bendazac e dei suoi sali nel trattamento della retinite pigmentosa
IT1197805B (it) 1986-08-01 1988-12-06 Acraf Metodo per il tratamento di lenti a contatto

Also Published As

Publication number Publication date
UA26852C2 (uk) 1999-12-29
RU2044729C1 (ru) 1995-09-27
CA2009503A1 (en) 1990-08-07
CA2009503C (en) 2000-04-11
DE69021902T2 (de) 1996-05-23
ATE127115T1 (de) 1995-09-15
DK0382276T3 (da) 1996-01-15
SK56390A3 (en) 1997-05-07
PL163720B1 (pl) 1994-04-29
IL93132A (en) 1994-05-30
SK278441B6 (en) 1997-05-07
BG50273A3 (en) 1992-06-15
AU4906690A (en) 1990-08-16
US5112986A (en) 1992-05-12
EG19170A (en) 1994-11-30
DD295363A5 (de) 1991-10-31
PL163730B1 (pl) 1994-04-29
EP0382276B1 (en) 1995-08-30
ES2020171A4 (es) 1991-08-01
PT93067A (pt) 1990-08-31
DD291995A5 (de) 1991-07-18
HU204793B (en) 1992-02-28
RO106252B1 (ro) 1993-03-31
LT3604B (en) 1995-12-27
PH26552A (en) 1992-08-19
CN1046505C (zh) 1999-11-17
IN170957B (enExample) 1992-06-20
YU47943B (sh) 1996-07-24
CZ280121B6 (cs) 1995-11-15
JP2870925B2 (ja) 1999-03-17
FI900577A0 (fi) 1990-02-06
JPH02240065A (ja) 1990-09-25
RU2066318C1 (ru) 1996-09-10
EP0382276A3 (en) 1990-12-12
US4999367A (en) 1991-03-12
LTIP872A (en) 1995-03-27
DE69021902D1 (de) 1995-10-05
GR910300073T1 (en) 1991-11-15
PE25091A1 (es) 1991-08-17
HUT53088A (en) 1990-09-28
PT93067B (pt) 1995-12-29
YU20690A (sh) 1992-07-20
LV10612A (lv) 1995-04-20
IT1230441B (it) 1991-10-23
CN1088201A (zh) 1994-06-22
FI102678B (fi) 1999-01-29
EP0382276A2 (en) 1990-08-16
CZ56390A3 (en) 1995-06-14
ZA90644B (en) 1991-01-30
RU2055071C1 (ru) 1996-02-27
HU900689D0 (en) 1990-04-28
DE382276T1 (de) 1991-11-28
NZ232258A (en) 1991-06-25
KR900012913A (ko) 1990-09-03
AU624895B2 (en) 1992-06-25
IT8947620A0 (it) 1989-02-07
AR247386A1 (es) 1994-12-29
CN1034016C (zh) 1997-02-12
CN1044810A (zh) 1990-08-22
GR3018165T3 (en) 1996-02-29
IL93132A0 (en) 1990-11-05
ES2020171T3 (es) 1995-12-01
FI102678B1 (fi) 1999-01-29
GEP19971030B (en) 1997-06-13
LV10612B (en) 1995-08-20

Similar Documents

Publication Publication Date Title
US4999367A (en) Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids, compositions and use
KR880002310B1 (ko) 펜에탄올 아민류의 제조방법
FR2576901A1 (fr) Nouveaux derives de l'acide a-(oxo-2 hexahydro-2,4,5,6,7,7a thieno (3,2-c) pyridyl-5) phenyl acetique, leur procede de preparation et leur application therapeutique
JPH0735371B2 (ja) 新規なオキサゾロピリジン誘導体、これらの製造法およびそれらを含む製薬組成物
LU85634A1 (fr) Nouveaux derives de la carboxymethoxy-7 furo-(3,4-c)-pyridine,leur preparation et compositions therapeutiques a base de ces composes
WO1999061403A1 (en) Novel vinylbenzene derivatives
EP0643701B1 (fr) Composes derives de benzimidazole, leur procede de preparation et leur utilisation dans les domaines therapeutique et cosmetique
EP0021857B1 (fr) Dérivés de l'indole, leur préparation et medicaments les contenant
US4461894A (en) Naphth[1,2-d]imidazoles
JPWO1994001392A1 (ja) （−）−リトドリン
CH633251A5 (fr) Acide cyclohexanecarboxylique et ses derives.
KR890000638B1 (ko) 페노티아진 유도체의 제조방법
PT99589A (pt) Processo para a preparacao de novos derivados da benzo-selenazolinona e de composicoes farmaceuticas que os contem
FR2514355A1 (fr) Derives de biphenyl alcoyl carboxylates, leur procede de preparation et leur utilisation comme medicaments
JPS6399057A (ja) グリシン誘導体
US4532249A (en) Derivatives of p-acylaminophenol having a therapeutic action, and compositions having a therapeutic action containing said derivatives as pharmacologically active ingredients
EP0058009A1 (en) Novel benzanilide derivatives and pharmaceutical compositions containing them
SI9010206A (sl) Etri 1-benzil-3-hidroksimetil-indazola z alifatskimi 2-hidroksi kislinami
EP0145304B1 (en) Tetrahydro-beta-carboline derivatives and process for the preparation thereof
KR790001824B1 (ko) 비페닐옥시-유도체의 제조방법
FR2470116A1 (fr) Derives benzylideniques, leur preparation et leur application en therapeutique
GB1565936A (en) 4-(2-thienylmethylamino)benzoic acid compounds
BG51352A3 (bg) Метод за получаване на етери на 1-бензил-3- хидроксиметил-индазол
JPS6245869B2 (enExample)
JPH0413682A (ja) カテコール誘導体

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 11

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 12

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 13

FPAY Annual fee payment

Payment date: 20110415

Year of fee payment: 14

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 14

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20120502

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20120502